Eating disorders are on the rise. GLP-1s could make things worse.

T1Covered by 1 source · first reported by MIT Technology Review at 30 Oct, 09:00 UTC

GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders. A new report suggests that the global incidence of anorexia nervosa and bulimia nervosa…

science

Sources

• T1Eating disorders are on the rise. GLP-1s could make things worse.MIT Technology Review30 Oct, 09:00